Department of Rehabilitation and Human Performance and Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Telemed J E Health. 2021 Jun;27(6):641-648. doi: 10.1089/tmj.2020.0339. Epub 2020 Oct 13.
Coronavirus disease 2019 (COVID-19) poses a global public health emergency, overwhelming health systems worldwide and forcing rapid adoption of telemedicine strategies. The COVID-19 Precision Recovery Program (PRP) is a remote patient monitoring (RPM) clinical program that was deployed by a New York health system to perform physiologic and symptomatic monitoring for patients with confirmed or suspected COVID-19 diagnoses. The present cross-sectional descriptive study reports retrospective data collected from the PRP during the COVID-19 crisis in New York. One hundred twelve patients were included; mean (standard deviation) age was 49 (17.6) years and 60.7% were female. Most prevalent reported comorbidities were hypertension (36.3%), hypercholesterolemia (26.5%), and diabetes (17.7%). Less than half (44.6%) had a positive polymerase chain reaction COVID test (PCR-test), 33% had an unknown COVID status, and 17.9% had a negative test result. The most commonly reported symptoms included dyspnea (55.4%) and anxiety (55.4%). Anxiety was ranked as the most severe symptom (9.8%), followed by difficulty concentrating (4.5%). Symptom presentation did not significantly differ based on PCR-test status. RPM can be a valuable tool for delivering care to patients with confirmed or suspected COVID-19 diagnoses. Considering similarities in symptom presentation between PCR-test statuses, access to COVID-related clinical care should not be based on PCR-test results. RPM has strong potential to assist in the effective management of suspected COVID-19 patients.
2019 年冠状病毒病（COVID-19）构成了全球公共卫生紧急事件，使世界各地的卫生系统不堪重负，并迫使迅速采用远程医疗策略。COVID-19 精准康复计划（PRP）是一种远程患者监测（RPM）临床计划，由纽约一家卫生系统部署，用于对确诊或疑似 COVID-19 诊断的患者进行生理和症状监测。本横断面描述性研究报告了在纽约 COVID-19 危机期间从 PRP 收集的回顾性数据。共纳入 112 例患者；平均（标准差）年龄为 49（17.6）岁，60.7%为女性。最常见报告的合并症是高血压（36.3%）、高胆固醇血症（26.5%）和糖尿病（17.7%）。不到一半（44.6%）的患者聚合酶链反应 COVID 检测（PCR 检测）呈阳性，33%的患者 COVID 状态未知，17.9%的患者检测结果为阴性。最常见的报告症状包括呼吸困难（55.4%）和焦虑（55.4%）。焦虑被评为最严重的症状（9.8%），其次是注意力集中困难（4.5%）。PCR 检测状态对症状表现没有显著影响。RPM 可以成为为确诊或疑似 COVID-19 诊断患者提供护理的有价值工具。鉴于 PCR 检测状态之间存在相似的症状表现，COVID 相关临床护理的获取不应基于 PCR 检测结果。RPM 具有协助有效管理疑似 COVID-19 患者的巨大潜力。
